These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31619667)

  • 1. NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma.
    Frisira E; Rashid F; Varma SN; Badodi S; Benjamin-Ombo VA; Michod D; Niklison-Chirou MV
    Cell Death Dis; 2019 Oct; 10(11):785. PubMed ID: 31619667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
    Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
    Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma.
    Chauhan D; Singh AV; Ciccarelli B; Richardson PG; Palladino MA; Anderson KC
    Blood; 2010 Jan; 115(4):834-45. PubMed ID: 19965674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model.
    Singh AV; Palladino MA; Lloyd GK; Potts BC; Chauhan D; Anderson KC
    Br J Haematol; 2010 May; 149(4):550-9. PubMed ID: 20331453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Proteasome Inhibitor CEP-18770 Induces Cell Death in Medulloblastoma.
    Nath Varma S; Ye S; Ferlin S; Comer C; Cotton K; Niklison-Chirou MV
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells.
    Miller CP; Ban K; Dujka ME; McConkey DJ; Munsell M; Palladino M; Chandra J
    Blood; 2007 Jul; 110(1):267-77. PubMed ID: 17356134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.
    Yu CC; Chiou GY; Lee YY; Chang YL; Huang PI; Cheng YW; Tai LK; Ku HH; Chiou SH; Wong TT
    Childs Nerv Syst; 2010 Jul; 26(7):897-904. PubMed ID: 20179950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel proteasome inhibitor NPI-0052 as an anticancer therapy.
    Chauhan D; Hideshima T; Anderson KC
    Br J Cancer; 2006 Oct; 95(8):961-5. PubMed ID: 17047643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.
    Crowther AJ; Ocasio JK; Fang F; Meidinger J; Wu J; Deal AM; Chang SX; Yuan H; Schmid R; Davis I; Gershon TR
    Cancer Res; 2016 Jun; 76(11):3211-23. PubMed ID: 27197166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia.
    Ruiz S; Krupnik Y; Keating M; Chandra J; Palladino M; McConkey D
    Mol Cancer Ther; 2006 Jul; 5(7):1836-43. PubMed ID: 16891470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
    Chauhan D; Catley L; Li G; Podar K; Hideshima T; Velankar M; Mitsiades C; Mitsiades N; Yasui H; Letai A; Ovaa H; Berkers C; Nicholson B; Chao TH; Neuteboom ST; Richardson P; Palladino MA; Anderson KC
    Cancer Cell; 2005 Nov; 8(5):407-19. PubMed ID: 16286248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the role and clinical implications of proteasome inhibition in medulloblastoma.
    Hoerig CM; Plant-Fox AS; Pulley MD; Di K; Bota DA
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29168. PubMed ID: 34114315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
    Chen SM; Li YY; Tu CH; Salazar N; Tseng YY; Huang SF; Hsieh LL; Lui TN
    PLoS One; 2016; 11(8):e0161299. PubMed ID: 27537345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.
    Markowitz D; Powell C; Tran NL; Berens ME; Ryken TC; Vanan M; Rosen L; He M; Sun S; Symons M; Al-Abed Y; Ruggieri R
    Mol Cancer Ther; 2016 Aug; 15(8):1799-808. PubMed ID: 27207779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
    Patties I; Kortmann RD; Menzel F; Glasow A
    J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
    Levin N; Spencer A; Harrison SJ; Chauhan D; Burrows FJ; Anderson KC; Reich SD; Richardson PG; Trikha M
    Br J Haematol; 2016 Sep; 174(5):711-20. PubMed ID: 27161872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life in Paediatric Survivors of Medulloblastoma.
    Tariq R; Saeed Baqai MW; Shamim MS
    J Pak Med Assoc; 2022 Nov; 72(11):2339-2340. PubMed ID: 37013321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
    BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
    Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
    Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.